iih glp-1 Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention JAMA - Most viewed this
Description
Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes
doi:10.1038/s41584-025-01302-0
2016;167(3):843-857.e814
The UK's NHS has begun evaluating GLP-1 obesity coverage, with NICE's appraisal of semaglutide for obesity resulting in conditional approval for use through specialist weight management services a restrictive but meaningful coverage expansion that will grow over time as service capacity expands
10.1007/s00125-012-2534-0 74
All other plans require you to continue making payments until the end of your term, even if you are no longer using the program
